Health Care • Biotechnology: Electromedical & Electrotherapeutic Apparatus
$67.12 ▲ +0.22
(+0.33%)
MKT CAP: $2.33B • VOL: 991.4K
52W L $60 52W H $156
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$56
MEDIAN
$75
MEAN
$77
HIGH
$91
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE TMDX TAPE
TMDX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $81.22 | $77.19 | 2025-02-14 | $61.08 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $84.57 | $79.20 | 2025-02-06 | $63.09 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $76.52 | $73.83 | 2025-01-29 | $64.44 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $68.46 | — | 2025-01-17 | $65.78 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $59.07 | $63.76 | 2025-01-09 | $59.74 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $79.87 | $69.80 | 2024-12-18 | $58.39 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $65.11 | $67.79 | 2024-12-04 | $62.42 | -4.3% | 48% | C |